2024 / 03 / 29

PharmaEssentian US subsidiary team participates in community charity events

To collate “Cheeriodicals” care kits for pediatric patients at the Arnold Palmer Hospital for Children

2024 / 02 / 15

PharmaEssentia Taiwan's premier and sole biotech company selected for the 2024 S&P Global Sustainability Yearbook

In 2023, ESG performance ranked 98 percentile globally within the biotech industry

2024 / 01 / 31

PharmaEssentian officially launched The OHS Committee ,and approved to implement the ISO 45001 international standard

Establish an OHS Committee, train employee’s awareness, contribute to addressing multiple SDGs

2023 / 12 / 25

PharmaEssentia Advances Telehealth in Rural Communities, Introduces AI Digital Care Education at Collaborative Sites

Continuously Caring for the Elderly Vulnerable, Advocating for a Friendly and Inclusive Community

2023 / 11 / 15

PharmaEssentia Clinches Dual Honors in Sustainable Report Awards: Receives TCSA Platinum Award & GCSA Bronze Award

Commended for Deep Commitment to SDG3 and Recognized for Outstanding ESG Achievements

2023 / 10 / 26

PharmaEssentia Announces Entry into 2023~2024 Sustainable Leap Year

Expanding Data Collection, Initiating Double Materiality Principles,and implementing TCFD Scenario Analysis

2023 / 09 / 28

PharmaEssentia ESG Sustainability Center Unveils 2023 ESG Education Training Series

Review Our ESG Journey, and Enhance Resource Allocation Focus and Strengthen Corporate Resilience

2023 / 08 / 31

Stepping Up Environmental Sustainability: PharmaEssentia Taichung Plant Broadens Annual Greenhouse Gas Inspection

Revitalizing Eco-Friendly Environment with the Continuation of the 2022 ISO 14064-1 GHG Inspection Project

2023 / 07 / 21

MPN Asia – Promote Social Inclusion and Sustainable Wellbeing and Healthy Development Goal

2023 Asia-Pacific Sustainability Action Awards -Sustainability Action Award SDG3:Silver

2023 / 07 / 21

Achieves Dual Honors at the 2023 Asia Pacific and Taiwan Sustainable Action Awards, Recognizing its Commitment to Sustainable Health and Social Inclusion

MPN Asia International Annual Conference Won APSAA Silver Award & TSAA Bronze Award

2023 / 07 / 12

PharmaEssentia embraces a culture of workplace safety, aiming to enhance employees' emergency response and first aid capabilities

Protecting workers' rights (SDG8) and establishing a safe and healthy work environment (SDG12)

2023 / 06 / 30

PharmaEssentia (stock code: 6446) has released its 4th-year "2022 Corporate Sustainability Report"

Year of Performance Progress Communication, we presented a total of 51 ESG highlights

2023 / 05 / 30

Reuse Old Computers: Reduce Emissions, Sustain Value

Promoting Environmental Sustainability, SDG 5, SDG 12, and SDG 13

2023 / 04 / 24

PharmaEssentia 2022 Sustainability Report Receives Independent Assurance Statement from Third-Party Verification Agency

Expands Assurance Scope to Overseas and Enhances Reporting with New Indicators and Quantitative Content

2023 / 03 / 16

Improving emergency response capabilities, PharmaEssentia Taipei office has successfully completed the professional training

Creating an efficient emergency response team and ensuring employee safety

2023 / 02 / 24

PharmaEssentia contributed local healthcare capacity building and accelerated healthcare efficiency

2022 / 12 / 21

PharmaEssentia supported Healthy Aging In Place , contributed to Rural Health Promotion Philanthropy

2022 / 12 / 09

PharmaEssentia sponsored Jane Goodall Institute Taiwan to replace refrigerants and reduce carbon emissions

2022 / 11 / 16

PharmaEssentia Won TCSA Platinum Award Chinese Report & Bronze Award English Report by GCSA

2022 / 10 / 25

PharmaEssentia Executive Center for Corporate Sustainability kicks off 2022-2023 ESG meeting and training

More than 100 employees participated proactively for achieving ESG goals of Corporate sustainability

2022 / 10 / 12

PharmaEssentia Health Talk: Office Human Factors Prevention and Stretching

2022 / 09 / 15

PharmaEssentia Climate Governance of Taipei : GHG management and internal verifier education & training

2022 / 09 / 12

PharmaEssentia Health Talk : Keep away from Metabolic Syndrome

2022 / 08 / 02

The Execution Center for Corporate Sustainability hold the first ESG education and training in 2022

2022 / 07 / 25

PharmaEssentia Climate Governance : GHG management and internal verifier education & training

2022 / 06 / 30

PharmaEssentia(6446) earns top ESG scores and announces to release 2021 Sustainability Reports both in English and Chinese simultaneously today

2022 / 06 / 22

PHARMAESSENTIA HONORED AT THE NATIONAL ORGANIZATION OF RARE DISORDERS (NORD®) 2022 RARE IMPACT AWARDS FOR THE INTRODUCTION OF BESREMI® (ROPEGINTERFERON ALFA-2B-NJFT) FOR POLYCYTHEMIA VERA

2022 / 05 / 24

PharmaEssentia Compliance training: IRPMA COP Updates and Remind

2022 / 04 / 27

Pharmaessentia Japan Files Marketing Authorization Application for Ropeginterferon Alfa-2b for the Treatment of Polycythemia Vera

2022 / 04 / 25

PharmaEssentia exercises the cybersecurity and data privacy protection social engineering online education & training

2022 / 04 / 17

Announcement of the Top-line Results of the Phase I clinical trial of KX01 for Actinic Keratosis (AK) in Japan on Behalf of Subsidiary PharmaEssentia Japan KK

2022 / 03 / 29

PharmaEssentia and Chiayi Chang-Geng Memorial Hospital establish the first MPN Center in Taiwan to practice the governance of Access to Medicine

2022 / 03 / 02

NCCN CLINICAL PRACTICE GUIDELINES IN ONCOLOGY UPDATE RECOMMENDS BESREMi® (ROPEGINTERFERON ALFA-2B-NJFT) FOR THE TREATMENT OF POLYCYTHEMIA VERA

2022 / 03 / 02

The NCCN Guidelines has included Besremi (Ropeginterferon alfa-2b) as a recommended therapeutic option for Adults with Polycythemia Vera (PV)

2022 / 02 / 25

PharmaEssentia has expanded the diversified perspective and re-identified the stakeholders and the materiality matrix of sustainability topics in the 3rd ESG Year

2022 / 02 / 14

The Company Announces Completion of Application of the

2022 / 01 / 25

PharmaEssentia Legal Risk Talk : Legal Risk Arising from Wrongful and Dishonest Workplace Conduct

2021 / 12 / 01

3rd PharmaEssentia ESG Sustainability Center Kick-Off Meeting and training

2021 / 11 / 17

PharmaEssentia 2020 ESG Sustainability Report Won The First Gold Award

2021 / 10 / 21

PharmaEssentia Health Talk : Cardiovascular Knowledge and Prevention

2021 / 09 / 24

The Execution Center for Corporate Sustainability hold the second ESG education and training in September

2021 / 09 / 16

PharmaEssentia releases English Sustainability Report for 2020 and new ESG Website

2021 / 08 / 31

PharmaEssentia officially launched TCFD (Task Force on Climate-Related Financial Disclosures) education and training today

2021 / 07 / 30

PharmaEssentia published the Sustainability Report and ranked among the top 15% of global biotechnology

Commercial Times, July 30,2021

2021 / 07 / 30

PharmaEssentia grasped the sustainable highlights of ESG and the international sustainability rating has been upgraded

Economy Daily News, July 30,2021

2021 / 07 / 28

PharmaEssentia published the Second Chinese Version of ” 2020 Sustainability Report ” and the New Website of ESG

2021 / 05 / 07

The “ 2020 Sustainability Report ” has obtained the Statement of Independent Assurance Opinion guaranteed by BSI Taiwan

2021 / 04 / 30

The company has sustained to Top 6%~20% range on the 2020 Corporate Governance Evaluation Results

2021 / 03 / 15

Completed the second ESG non-financial risk education and training, identified ESG materiality risk topics and non-financial risk matrix

2021 / 01 / 15

" COSO ERM” was introduced for the first time to conduct the first ESG non-financial risk education and training for the five taskforces team members

2020 / 12 / 30

PharmaEssentia published the First English Version of “ 2019 Sustainability Report ”

2020 / 11 / 30

To optimize the implementation and Improvement of the sustainability project, we launch the second phase of the sustainability blueprint to focus on the connectivity between SDGs and SASB.

2020 / 10 / 15

The Execution Center for Corporate Sustainability introduced "SMART" management principle for the first time to educate and train the five taskforces team members

2020 / 09 / 30

PharmaEssentia published the First Chinese Version of ” 2019 Sustainability Report ”

2020 / 07 / 15

The Execution Center for Corporate Sustainability and five taskforces were formally established to jointly manage materiality of sustainability topics

2020 / 04 / 30

The company has promoted to Top 6%~20% range on the 2019 Corporate Governance Evaluation Results

2020 / 04 / 15

Established the Execution Center for Corporate Sustainability for the first time and completed sustainability training for all employees in five taskforces

2020 / 03 / 16

The first analysis, study and response to Sustainalytics, MSCI sustainability assessment

2020 / 02 / 16

Start the first year of corporate sustainability, and instill 100% of corporate sustainability DNA

2019 / 11 / 15

All directors take a continuing education arrangement on corporate sustainability

2019 / 10 / 15

Launched a 5-year sustainable development strategy and blueprint for the first time